SRS with Immunotherapy Extends Survival in RCC with Brain Metastasis

Metagenomic next-generation sequencing in osteoarticular infections with a focus on pediatrics: current concepts and clinical applications

Manmeet Ahluwalia, MD


According to Manmeet Ahluwalia, MD, MBA, FASCO, kidney cancer currently ranks as the fourth most common cancer to metastasize to the brain after lung cancer, breast cancer, and melanoma. While it is challenging to predict the exact proportion of patients with kidney cancer who will develop brain metastases, he estimates it to be approximately 10% to 15% of patients with stage IV disease.